402 related articles for article (PubMed ID: 25852107)
1. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
Saneeymehri SS; Markey KR; Mahipal A
J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
3. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
Scott PA; Ferchow L; Hobson A; Curzen NP
Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
[TBL] [Abstract][Full Text] [Related]
4. Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
Lampropoulos S; Roditis P; Koulouris E; Zafiris A; Tzimou M; Kyratlidis K; Pavlidis K; Godwin SA; Kosmas C
Anticancer Drugs; 2017 Aug; 28(7):801-807. PubMed ID: 28489615
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine-induced chest pain relieved by diltiazem.
Ambrosy AP; Kunz PL; Fisher GA; Witteles RM
Am J Cardiol; 2012 Dec; 110(11):1623-6. PubMed ID: 22939579
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
[TBL] [Abstract][Full Text] [Related]
7. Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.
Kwakman JJ; Simkens LH; Mol L; Kok WE; Koopman M; Punt CJ
Eur J Cancer; 2017 May; 76():93-99. PubMed ID: 28286287
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
9. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
[TBL] [Abstract][Full Text] [Related]
10. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
Shah NR; Shah A; Rather A
J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
12. 5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.
McGlinchey PG; Webb ST; Campbell NP
BMC Cardiovasc Disord; 2001; 1():3. PubMed ID: 11734065
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine cardiotoxicity--case reports and literature review.
Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations.
Teperikidis E; Boulmpou A; Charalampidis P; Tsavousoglou C; Giannakoulas G; Papadopoulos CE; Vassilikos V
Acta Cardiol; 2022 Feb; 77(1):1-13. PubMed ID: 33683181
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.
Shahrokni A; Rajebi MR; Harold L; Saif MW
JOP; 2009 Mar; 10(2):215-20. PubMed ID: 19287123
[TBL] [Abstract][Full Text] [Related]
18. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
19. A case of coronary spasm induced by 5-fluorouracil.
Gorgulu S; Celik S; Tezel T
Acta Cardiol; 2002 Oct; 57(5):381-3. PubMed ID: 12405579
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
